MiNK Therapeutics News

MiNK Therapeutics | 8-K: Current report

May 16 08:06 ET

MiNK Therapeutics | 8-K: MiNK Reports First Quarter 2024 Results

May 14 07:34 ET

MiNK Therapeutics | DEF 14A: Definitive information statements

Apr 29 17:30 ET

MiNK Therapeutics | 8-K: MiNK Reports Fourth Quarter and Year-End 2023 Results

Mar 21 07:05 ET

MiNK Therapeutics | 8-K: Current report

Feb 29 16:18 ET

MiNK Therapeutics | 8-K: Current report

Feb 14 08:04 ET

MiNK Therapeutics | 8-K: Current report

Nov 9, 2023 07:00 ET

MiNK Therapeutics | 8-K: Current report

Oct 17, 2023 16:15 ET

MiNK Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 11, 2023 07:44 ET

MiNK Therapeutics | 8-K: Current report

Aug 10, 2023 07:30 ET

MiNK Therapeutics | 8-K: Current report

Jun 20, 2023 15:45 ET

MiNK Therapeutics | 8-K: MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results

May 11, 2023 08:00 ET

MiNK Therapeutics | DEF 14A: Definitive proxy statements

May 1, 2023 15:00 ET

MiNK Therapeutics | 8-K: MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 21, 2023 08:00 ET

MiNK Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Nov 3, 2022 17:05 ET

MiNK Therapeutics | 8-K: MiNK Therapeutics Reports Corporate Update and Third Quarter 2022 Financial Results

Nov 3, 2022 08:01 ET

MiNK Therapeutics | 8-K: MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results

Aug 9, 2022 08:00 ET

MiNK Therapeutics | 8-K: Current report

Aug 5, 2022 16:31 ET

MiNK Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jul 15, 2022 16:44 ET

MiNK Therapeutics | 8-K: Current report

Jun 14, 2022 16:58 ET